Ajanta Pharma Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore)
Ajanta Pharma Ltd · Outcome · 30 Oct 2026, 6:25 pm
Ajanta Pharma Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore) ■ Revenue: 1,794 (+32.5% YoY | +10.3% QoQ) ■ EBITDA: 548 (+67.0% YoY | +29.3% QoQ) ■ EBITDA Margin (%): 30.5 (+630 bps YoY | +447 bps QoQ) ■ PAT: 388 (+49.2% YoY | +16.1% QoQ) ■ EPS (INR): 31.0 (+49.0% YoY | +16.1% QoQ)
Original exchange filing (PDF)
More announcements from Ajanta Pharma Ltd
- The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 18, 2026 for Aayush Agrawal, .... · 18 Nov 2026
- The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 16, 2026 for Aayush Agrawal, .... · 17 Nov 2026
- The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 09, 2026 for Aayush Agrawal, .... · 09 Nov 2026
- Pls find enclosed Earnings Call Written Transcript · 04 Nov 2026
- Pls find enclosed Audio recording of Earnings Call · 30 Oct 2026
- Ajanta Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 30 Oct 2026
- Pls find enclosed results for the quarter ended 30.09.2026. · 30 Oct 2026
- The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 19, 2026 for Aayush Agrawal, trustee .... · 21 Oct 2026
